GLYCOPYRROLATE MSDS PDF

SAFETY DATA SHEET. PRODUCT: Glycopyrrolate Injection USP. Section 1: PRODUCT AND COMPANY INFORMATION. 54/1, Boodhihal village,. Nelamangala. Glycopyrrolate. 1-Methylpyrrolidyl alpha-phenylcyclopentaneglycolate methobromide;. Glycopyrrolate bromide; Glycopyrronium bromide. Glycopyrronium (as the bromide salt glycopyrrolate) is a synthetic anticholinergic agent In October , glycopyrrolate was approved by the FDA for use as a FDA label. Download ( KB). MSDS. Download ( KB).

Author: Kilmaran Baramar
Country: Papua New Guinea
Language: English (Spanish)
Genre: History
Published (Last): 9 July 2018
Pages: 41
PDF File Size: 11.52 Mb
ePub File Size: 4.55 Mb
ISBN: 979-2-63067-150-6
Downloads: 42038
Price: Free* [*Free Regsitration Required]
Uploader: Kesida

The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Hexafluronium. Tubocurarine The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Tubocurarine. Physostigmine The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Physostigmine. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Mephentermine.

Cannabidiol The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined glycoyprrolate Cannabidiol. Oxyphenonium The glycopyrrolzte or severity of adverse effects can be increased when Oxyphenonium is combined with Glycopyrronium. Levosalbutamol The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Levosalbutamol.

The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Abediterol. Nicomorphine The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Nicomorphine.

Orphenadrine The risk or glycopyrrolste of adverse effects can be increased when Orphenadrine is combined with Glycopyrronium.

Lisdexamfetamine The risk or severity of Tachycardia can be increased when Glycopyrrolatw is combined with Lisdexamfetamine. The risk or severity of Tachycardia can be increased when Midodrine is combined with Glycopyrronium. Diethylcarbamazine The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Diethylcarbamazine.

The risk or severity of Tachycardia can be increased when Methoxamine is combined with Msde. Amobarbital Glycopyrronium may increase the anticholinergic activities of Amobarbital. Umeclidinium The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Umeclidinium.

  LETTER TO THE SOLDIERS OF COROTICUS PDF

Picosulfuric acid The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Glycopyrronium. Fenpiverinium The risk or severity of adverse effects can be increased when Fenpiverinium is combined with Glycopyrronium. Quetiapine The risk or severity of adverse effects can be increased when Quetiapine is combined with Glycopyrronium.

Dextroamphetamine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Dextroamphetamine. Micronomicin The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Micronomicin.

DrugBank does not sell nor buy drugs. Higenamine The glycopyrrolzte or severity of Tachycardia can be increased when Glycopyrronium is combined mds Higenamine. The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Glycopyrronium.

Glycopyrronium

Neomycin The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Neomycin. Cocaine The risk or severity of adverse effects can be increased when Cocaine is combined with Glycopyrronium. Bambuterol The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Bambuterol.

Tretoquinol The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Tretoquinol. Benzquinamide The risk or severity of adverse effects can be increased when Benzquinamide is combined with Glycopyrronium. The risk or severity of adverse ,sds can be increased when Glycopyrronium is combined with Dihydrocodeine. The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Ambenonium.

Trichlormethiazide The serum concentration of Trichlormethiazide can be increased when it is combined with Glycopyrronium. Talbutal Talbutal may increase the anticholinergic activities of Glycopyrronium. Benzthiazide The serum concentration of Benzthiazide can be increased when it is combined with Glycopyrronium.

Metrifonate The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Metrifonate. Lofexidine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Lofexidine.

  JJ BENITEZ EL TESTAMENTO DE SAN JUAN PDF

The risk glycopyrrolaate severity glycopyrroltae adverse effects can be increased when Nicardipine is combined with Glycopyrronium. Guanfacine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Guanfacine. The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Alphaprodine. The therapeutic efficacy of Glycopyrronium can flycopyrrolate decreased when used in combination with Hygromycin B.

Glycopyrronium – DrugBank

The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Alphacetylmethadol. The risk or severity of Tachycardia can be increased when Bitolterol is combined with Glycopyrronium. Chlorthalidone The serum concentration of Chlorthalidone can be increased when it is combined with Glycopyrronium. Glycopyrronium as the bromide salt glycopyrrolate is a synthetic anticholinergic agent with a quaternary ammonium structure.

The risk or severity of urinary retention can be increased when Glycopyrronium is combined with Mirabegron. Levonordefrin The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Levonordefrin. Ramosetron The risk or severity of constipation msdz be increased when Glycopyrronium is combined with Ramosetron. Carfentanil The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Carfentanil. Dicyclomine The risk or severity of adverse effects can be increased when Dicyclomine is combined with Glycopyrronium.

The risk or severity of adverse effects can be increased when Glgcopyrrolate Methylbromide is combined with Glycopyrronium. The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with GW